FERMENTA BIOTECH LIMITED (FERMENTA.BO)

INR 393.0

(-0.57%)

Long Term Debt Summary of FERMENTA BIOTECH LIMITED

FERMENTA BIOTECH LIMITED's latest annual long term debt in 2023 was 425.36 Million INR , down -49.11% from previous year.
FERMENTA BIOTECH LIMITED's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
FERMENTA BIOTECH LIMITED reported annual long term debt of 835.89 Million INR in 2022, down -27.11% from previous year.
FERMENTA BIOTECH LIMITED reported annual long term debt of 1.14 Billion INR in 2021, up 3.84% from previous year.
FERMENTA BIOTECH LIMITED reported quarterly long term debt of 425.36 Million INR for 2023 FY, down -49.11% from previous quarter.
FERMENTA BIOTECH LIMITED reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of FERMENTA BIOTECH LIMITED (2023 - 2012)

Historical Annual Long Term Debt of FERMENTA BIOTECH LIMITED (2023 - 2012)

Year	Long Term Debt	Long Term Debt Growth
2023	425.36 Million INR	-49.11%
2022	835.89 Million INR	-27.11%
2021	1.14 Billion INR	3.84%
2020	1.1 Billion INR	8.5%
2019	1.01 Billion INR	-24.72%
2018	1.35 Billion INR	-0.12%
2017	1.35 Billion INR	235.74%
2016	403.19 Million INR	126.74%
2015	177.82 Million INR	232.13%
2014	53.54 Million INR	-78.45%
2013	248.4 Million INR	62.71%
2012	152.66 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- INR	-100.0%
2023 FY	425.36 Million INR	-49.11%
2023 Q1	- INR	-100.0%
2023 Q2	534.43 Million INR	0.0%
2023 Q4	425.36 Million INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q2	1.23 Billion INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q4	835.89 Million INR	0.0%
2022 FY	835.89 Million INR	-27.11%
2021 FY	1.14 Billion INR	3.84%
2021 Q4	1.14 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2021 Q2	1.03 Billion INR	0.0%
2021 Q3	- INR	-100.0%
2020 Q4	1.1 Billion INR	0.0%
2020 FY	1.1 Billion INR	8.5%
2020 Q1	- INR	-100.0%
2020 Q2	1.23 Billion INR	0.0%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 Q1	- INR	-100.0%
2019 FY	1.01 Billion INR	-24.72%
2019 Q2	1.22 Billion INR	0.0%
2019 Q4	1.04 Billion INR	0.0%
2018 Q4	1.35 Billion INR	0.0%
2018 FY	1.35 Billion INR	-0.12%
2018 Q3	- INR	-100.0%
2018 Q2	1.33 Billion INR	0.0%
2018 Q1	- INR	-100.0%
2017 Q2	508.01 Million INR	0.0%
2017 Q3	- INR	-100.0%
2017 Q4	1.35 Billion INR	0.0%
2017 FY	1.35 Billion INR	235.74%
2017 Q1	- INR	-100.0%
2016 FY	403.19 Million INR	126.74%
2016 Q4	403.19 Million INR	0.0%
2016 Q3	- INR	-100.0%
2016 Q2	364.16 Million INR	0.0%
2015 Q2	33.91 Million INR	0.0%
2015 Q1	- INR	-100.0%
2015 FY	177.82 Million INR	232.13%
2015 Q4	177.82 Million INR	0.0%
2015 Q3	- INR	-100.0%
2014 Q2	76.94 Million INR	0.0%
2014 Q3	- INR	-100.0%
2014 Q1	- INR	-100.0%
2014 FY	53.54 Million INR	-78.45%
2014 Q4	53.54 Million INR	0.0%
2013 FY	248.4 Million INR	62.71%
2013 Q3	- INR	-100.0%
2013 Q4	248.4 Million INR	0.0%
2013 Q2	123.48 Million INR	0.0%
2012 Q3	- INR	0.0%
2012 FY	152.66 Million INR	0.0%
2012 Q4	152.66 Million INR	0.0%

Peer Long Term Debt Comparison of FERMENTA BIOTECH LIMITED

Name	Long Term Debt	Long Term Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	68.643%
Biocon Limited	129.32 Billion INR	99.671%
Blue Jet Healthcare Limited	3.79 Million INR	-11123.219%
Concord Biotech Limited	18.87 Million INR	-2154.16%
Dishman Carbogen Amcis Limited	2.45 Billion INR	82.681%
GENOMIC VALLEY BIOTECH LIMITED	- INR	-Infinity%
Lyka Labs Limited	429.06 Million INR	0.864%
Panacea Biotec Limited	209.9 Million INR	-102.649%
SAMSRITA LABS LIMITED	- INR	-Infinity%
Servoteach Industries Limited	5059.00 INR	-8407885.768%
SMS Lifesciences India Limited	331.45 Million INR	-28.333%
Supriya Lifescience Limited	50.2 Million INR	-747.331%
Syngene International Limited	1 Billion INR	57.464%
TAKE Solutions Limited	7.5 Million INR	-5571.467%
Titan Biotech Limited	4.53 Million INR	-9283.631%
Transgene Biotek Limited	50.79 Million INR	-737.405%
Vanta Bioscience Limited	488.01 Million INR	12.839%